about
Synthesis and characterisation of thiosemicarbazonato molybdenum(VI) complexes and their in vitro antitumor activity.Plasma biomarker identification in S-adenosylhomocysteine hydrolase deficiency.Metastasis: new perspectives on an old problemProteomics profiling of keratocystic odontogenic tumours reveals AIDA as novel biomarker candidate.Global approach to perinatal medicine: functional genomics and proteomics.Novel pyrimidine-2,4-dione-1,2,3-triazole and furo[2,3-d]pyrimidine-2-one-1,2,3-triazole hybrids as potential anti-cancer agents: Synthesis, computational and X-ray analysis and biological evaluation.Discovery of New Acid Ceramidase-Targeted Acyclic 5-Alkynyl and 5-Heteroaryl Uracil Nucleosides.Inflammatory Gene Expression Upon TGF-β1-Induced p38 Activation in Primary Dupuytren's Disease Fibroblasts.Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?Towards preventive medicine. High-throughput methods from molecular biology are about to change daily clinical practice.Running for time: circadian rhythms and melanoma.Synthesis, in vitro anticancer and antibacterial activities and in silico studies of new 4-substituted 1,2,3-triazole-coumarin hybrids.Novel halogenated 3-deazapurine, 7-deazapurine and alkylated 9-deazapurine derivatives of L-ascorbic or imino-L-ascorbic acid: Synthesis, antitumour and antiviral activity evaluations.Novel phenyl and pyridyl substituted derivatives of isoindolines: Synthesis, antitumor activity and DNA binding features.Synthesis and in vitro antiproliferative evaluation of novel N-alkylated 6-isobutyl- and propyl pyrimidine derivatives.Novel coumarin derivatives containing 1,2,4-triazole, 4,5-dicyanoimidazole and purine moieties: synthesis and evaluation of their cytostatic activity.Novel 1,2,4-triazole and imidazole derivatives of L-ascorbic and imino-ascorbic acid: synthesis, anti-HCV and antitumor activity evaluations.In vivo toxicity study of N-1-sulfonylcytosine derivatives and their mechanisms of action in cervical carcinoma cell line.The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations.Novel diamidino-substituted derivatives of phenyl benzothiazolyl and dibenzothiazolyl furans and thiophenes: synthesis, antiproliferative and DNA binding properties.Adenovirally mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatment.Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2-alpha]quinoline in colon cancer cells depending on their p53 status.A dual role of p21waf1/cip1 gene in apoptosis of HEp-2 treated with cisplatin or methotrexate.Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues.Novel lipophilic hydroxyurea derivatives: synthesis, cytostatic and antiviral activity evaluations.Novel thiosemicarbazone derivatives as potential antitumor agents: Synthesis, physicochemical and structural properties, DNA interactions and antiproliferative activity.Accelerating drug discovery.Evolving '-omics' technologies in the drug development process.Antiviral and cytostatic evaluation of the novel 6-acyclic chain substituted thymine derivatives.The novel pyrimidine and purine derivatives of l-ascorbic acid: synthesis, one- and two-dimensional 1H and 13C NMR study, cytostatic and antiviral evaluation.Do we understand the personalized medicine paradigm? Personalized medicine marks the beginning of a new attitude in medicine.Expression of growth hormone receptor, plakoglobin and NEDD9 protein in association with tumour progression and metastasis in human breast cancer.Synthesis, characterisation and in vitro investigation of photodynamic activity of 5-(4-octadecanamidophenyl)-10,15,20-tris(N-methylpyridinium-3-yl)porphyrin trichloride on HeLa cells using low light fluence rate.Synthesis and Anti-Proliferative Effects of Mono- and Bis-Purinomimetics Targeting Kinases.Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549.Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential.In vivo assessment of DNA damage induced in oral mucosa cells by fixed and removable metal prosthodontic appliances.Dual sphingosine kinase inhibitor SKI-II enhances sensitivity to 5-fluorouracil in hepatocellular carcinoma cells via suppression of osteopontin and FAK/IGF-1R signalling.Novel amidino substituted benzimidazole and benzothiazole benzo[b]thieno-2-carboxamides exert strong antiproliferative and DNA binding properties.
P50
Q33509430-15276FC4-83F2-400E-BEE1-DA91E1FD2650Q33952797-EFCDA8FE-B8CE-47FC-B9C9-D391CE61D5D4Q34639530-582C69C8-B535-40FB-81C2-42C4DEB71122Q35209476-FD555676-A734-48A6-A332-916F43B1F8B1Q36102697-A858D8AE-34D3-4A45-A3B6-30FA8E550901Q36201273-CB003700-9A7E-4718-B9CF-BCCF91FF1337Q36281044-162531B4-CF56-4FAC-9CB5-7E510769486EQ36352894-D4917E86-FE3D-4467-84F3-AF3B4AB07FD0Q36636837-079EE521-731A-46DA-BFAE-9C64147ED794Q36969281-FAED96C4-4862-46BD-814E-923F957F78BDQ38204315-8D6EC822-7B57-4282-B620-3E24F9AD46AEQ38745819-1E6FC0C2-10F0-4BAF-A262-D2C93E17A79DQ38842365-29DCB3A0-E542-4FAD-BEF1-626DCED85E61Q38950609-AADE62FD-F982-44CD-AF1F-F004D3983753Q38994311-B0960D75-4112-43BF-B87E-ADE5BB564F38Q39280328-51768671-78E2-4410-9815-CF79FADED2A9Q39354157-01E9571B-8E56-47AD-A9C7-03466D3BEB38Q39572610-3F9AD7E2-5AD7-4704-8E7F-90C3B9D0CBE2Q39669394-0956E55E-4006-4FC1-AFFF-59BEF1E41B55Q39737477-68029069-1BAF-4358-A789-4BDB89956F8CQ39834578-C02A66D4-6D80-43AF-BBEB-599D6D880C8BQ39958580-5A097833-2E87-4E6F-898C-4FF804E1D4CEQ39981678-F7D2F206-3C3C-4EC6-8EA9-5DD7B6F0CC9FQ39990506-E5642574-639F-4D66-9A3D-EC8F44B0E09CQ39992278-B893F525-5FA6-4C16-9735-CBF189CBD38CQ39999652-D09D7165-4FE4-4079-B30B-43B953A36519Q40104889-58AADB8D-1D67-43E1-A739-AF69845BA133Q40228498-B8B6E1D9-4049-4A5B-A67D-375CAA97E79BQ40358612-FFB939E2-5A06-41A8-855A-FAFF0AF92389Q40484140-5E3D4CB9-86DF-46D3-8883-58360E1F9267Q42104770-734A3723-8079-473F-BF53-D990B274C221Q46197377-3915E274-452C-43F1-876F-37C5B4767B44Q46514602-D062EE8A-9B1C-47AD-A8C0-BE5A22729EDAQ47161171-1745FE1B-D3F6-4706-9626-953D13223B24Q47224821-1B018E2A-0B74-4E9A-A55E-2125211D5392Q47353104-73C8DCDD-5F28-4EEB-8BCD-79D5927B1DE4Q47988612-46FD11BF-A6DB-47D5-B85C-08B120DC10C1Q50440100-F8C6D458-206F-4BE8-8769-6A4C238F8002Q50654322-374F8E08-BBD6-40F0-81CA-22146DF8EEB2Q50869126-EBBC1DB7-FFF4-4E77-8FC4-8DFCE25D8967
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Sandra Kraljević Pavelić
@ast
Sandra Kraljević Pavelić
@en
Sandra Kraljević Pavelić
@es
Sandra Kraljević Pavelić
@nl
type
label
Sandra Kraljević Pavelić
@ast
Sandra Kraljević Pavelić
@en
Sandra Kraljević Pavelić
@es
Sandra Kraljević Pavelić
@nl
prefLabel
Sandra Kraljević Pavelić
@ast
Sandra Kraljević Pavelić
@en
Sandra Kraljević Pavelić
@es
Sandra Kraljević Pavelić
@nl
P106
P1153
55892263300
P21
P31
P496
0000-0003-0491-673X